US loss of exclusivity · Oncology

Perjeta

Roche

2026US biosimilars from
2025Today: 20262037
2025 worldwide sales
≈$3.6B
Date basis
Company guidance
US biosimilars
Approved, waiting to launch
Pharma Patent Cliff by readouts.io Data checked 8 October 2026 · Full Perjeta timeline →